CRP and obesity due to melanocortin 4 receptor deficiency: Use of bDMARDs (β −0.22, p = 0.03) at follow-up remained associated with lower LV mass index at follow-up after adjustment for age, sex, obesity, and CRP levels in multivariable analyses (Table 3).